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Hydroxyapatite (HAp) Ca10(PO4)6(OH)2 is of significant interest in biomedical engineering due 
to its exceptional biocompatibility, bioactivity and osteoconductivity properties [1]. 
In this context, the present project aims at synthesizing HAp crystals with a carefully 
controlled size, with a controlled and narrow size distribution and with a high purity. Thus 
HAp crystals shall be produced with a high specific surface area, i.e. small crystals, and a 
high biocompatibility, making them suitable for application in bone substitution. 
The work should start by the characterization of HAp precipitation process, namely by the 
definition of the optimal operation conditions and the modelling of the process. First, the 
study will be conducted in a stirred tank. Once the system characterized, HAp precipitation 
will be carried out in a novel OFR developed by CEB-UMinho [2]. In fact, the OFR appears 
as a good candidate to promote ideal conditions, in particular in terms of micromixing, for the 
controllability of HAp particles properties. The effect of some additives with well defined roles 
in HAp precipitation will also be investigated. In parallel, the biocompatibility of the products 
developed will be evaluated, by determining the cytoxicity using cell lines (osteoblasts). 
Finally, the novel OFR will be tested for bone related cells culture, both in the absence and in 
the presence of HAp crystals.  
Initial experiments were performed in a 1L stirred tank, mixing a saturated solution of calcium 
with a solution of phosphate using different Ca/P molar ratios always at T=37ºC. After 
process optimization, a suspension of stoichiometric HAp particles with pH close to 7 was 
obtained for Ca/P=1.29. The particles formed possess a rod-like shape with dimensions of 
about 20 nanometers thick and 100 nanometers long, and proved to be high crystalline. In 
addition, HAp crystals revealed the tendency to aggregate in solution and had a narrow size 
distribution with a mean particle size of about 128 nm. 
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